NOT-DA-13-016: Notice of NIDA's Participation in RFA-NS-13-014 Pilot Projects on Sports-Related Brain and Spinal Cord Injury (R21)

Notice of NIDA's Participation in RFA-NS-13-014 "Pilot Projects on Sports-Related Brain and Spinal Cord Injury (R21)"

Notice Number: NOT-DA-13-016

Key Dates

Release Date: March 21, 2013

Related Announcements

RFA-NS-13-014

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to inform potential applicants of the National Institute on Drug Abuse (NIDA)'s intent to participate, effective immediately, in the Funding Opportunity Announcement (FOA) RFA-NS-13-014, entitled "Pilot Projects on Sports-Related Brain and Spinal Cord Injury (R21)."

RFA-NS-13-014 has been changed in the following ways to indicate NIDA's participation in this FOA.

Part 1. Overview Information

Components of Participating Organizations

National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute of Mental Health (NIMH)
National Institute on Drug Abuse (NIDA)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.853; 93.286; 93.242, 93.279

Part 2. Section I. Funding Opportunity Description

Specific Areas of Research Interest

For this FOA, specific topics of interest to NIDA include:

Interactive effects of prescribed stimulant or opiate medication use on TBI treatment outcomes or on brain or behavioral (including cognitive, emotional, and/or social) measures.

Examination of sports-related TBI effects on substance use outcomes.

Part 2. Section II. Award Information

Funds Available and Anticipated Number of Awards

NIDA support for this FOA is contingent on the availability of funds and the receipt of meritorious applications.

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)

James Bjork, Ph.D.
Clinical Neuroscience Branch

Division of Clinical Neuroscience and Behavioral Research

National Institute on Drug Abuse (NIDA)
Phone: 301-443-3209
Email: [email protected]

Financial/Grants Management Contact(s)

Maryellen Connell
Grants Management Branch
National Institute on Drug Abuse (NIDA)
Phone: 301-774-3803
Email: [email protected]

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

James Bjork, Ph.D.
Clinical Neuroscience Branch

Division of Clinical Neuroscience and Behavioral Research

National Institute on Drug Abuse (NIDA)
Phone: 301-443-3209
Email: [email protected]